Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?

Drings A, Jallet C, Chambert B, Tordo N, Perrin P

Open source

DOI
10.1016/s0264-410x(98)00357-0
Published
1999 Mar 17
Container
Vaccine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0264-410x-98-00357-0,
  title = {Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?},
  author = {Drings A and Jallet C and Chambert B and Tordo N and Perrin P},
  year = {1999},
  journal = {Vaccine},
  doi = {10.1016/s0264-410x(98)00357-0},
  url = {https://doi.org/10.1016/s0264-410x(98)00357-0}
}

RIS

TY  - JOUR
TI  - Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?
AU  - Drings A
AU  - Jallet C
AU  - Chambert B
AU  - Tordo N
AU  - Perrin P
PY  - 1999
JO  - Vaccine
DO  - 10.1016/s0264-410x(98)00357-0
UR  - https://doi.org/10.1016/s0264-410x(98)00357-0
ER  - 

APA

A, D., C, J., B, C., N, T., & P, P. (1999). Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?. Vaccine. https://doi.org/10.1016/s0264-410x(98)00357-0

Source records